The decide is anticipated to rule quickly on a chapter deal for OxyContin maker Purdue Pharma. The deal would give members of the Sackler household, who personal the corporate, immunity from any legal responsibility.
NOEL KING, HOST:
An enormous ruling coming right this moment within the chapter of Purdue Pharma, which makes the opioid OxyContin. At stake is whether or not a federal decide will grant immunity from future lawsuits to the corporate’s homeowners, members of the Sackler household.
NPR habit correspondent Brian Mann has been following this story for a very long time. Good morning, Brian.
BRIAN MANN, BYLINE: